Artemis Medicare Services Ltd. (ARTEMISMED) Share Price Hits 52-Week High
- August 4, 2026
- Posted by: Harsh Piplani
- Category: News
Artemis Medicare Services Ltd. Share Price reached a fresh 52-week high of Rs 308.05, with a market cap of Rs 4,708.82 crore. The stock rose by 0.18% today.
Artemis Medicare Services Ltd. Share Price has reached a fresh 52-week high of Rs 308.05, marking a significant milestone for the company. The stock opened at Rs 305.85 and closed at Rs 302.7, reflecting a day change of 0.55 points or 0.18%. The market capitalisation stands at Rs 4,708.82 crore, highlighting its position in the healthcare sector. This achievement underscores the company’s resilience and market interest, as investors continue to monitor its performance closely.
Artemis Medicare Services Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 302.7 |
| Previous Close | Rs 302.15 |
| Today's Change | +Rs 0.55 (+0.18%) |
| Day Open | Rs 305.85 |
| Fresh 52-Week High | Rs 308.05 |
| Day Low | Rs 300.75 |
| Current Volume | 10,076 |
| Turnover | Rs 0.31 crore |
| Market Capitalisation | Rs 4,708.82 crore |
Artemis Medicare Services Ltd. (ARTEMISMED) traded at Rs 302.7. versus the previous close of Rs 302.15, a rise of 0.18%. The stock opened at Rs 305.85, reached Rs 308.05, touched Rs 300.75. Reported volume was 10,076.
Today, Artemis Medicare Services Ltd. Share Price opened at Rs 305.85 and reached a high of Rs 308.05, setting a new 52-week peak. The stock closed at Rs 302.7, with a turnover of Rs 0.31 crore and a volume of 10,076 shares. The day’s low was Rs 300.75, indicating a range-bound session. The fresh 52-week high reflects positive sentiment among investors, although the day’s movement was relatively modest.
Artemis Medicare Services Ltd. (ARTEMISMED) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 4,708.82 crore |
| P/E Ratio | 39.39x |
| P/B Ratio | 7.98x |
| ROE | 28.21% |
| ROCE | 26.35% |
Artemis Medicare Services Ltd. was valued at a P/E ratio of 39.39x, a P/B ratio of 7.98x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of 28.21% and ROCE of 26.35%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 39.39x |
| Benchmark Median P/E | 20.89x |
| Benchmark Average P/E | 73.74x |
| Benchmark P/E Range | 0x to 3,364.06x |
| Company P/B Ratio | 7.98x |
| Benchmark Median P/B | 1.9x |
| Company ROE | 28.21% |
| Benchmark Median ROE | 10.92% |
| Company ROCE | 26.35% |
| Benchmark Median ROCE | 13.29% |
| Company Market Capitalisation | Rs 4,708.82 crore |
| Benchmark Median Market Cap | Rs 139.24 crore |
Artemis Medicare Services Ltd. (ARTEMISMED) is classified under sector: Healthcare.
Artemis Medicare Services Ltd. (ARTEMISMED) has a P/E ratio of 39.39x, which is above the benchmark median of 20.89x, a difference of +88.56%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Artemis Medicare Services Ltd. (ARTEMISMED) has a ROE of 28.21%, which is above the benchmark median of 10.92%, a difference of +158.33%. Artemis Medicare Services Ltd. (ARTEMISMED) has a ROCE of 26.35%, which is above the benchmark median of 13.29%, a difference of +98.27%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Kwality Pharmaceuticals Ltd. | KPL | 2,683.28 | 39.39 | 7.98 | 28.21 | 26.35 |
| Beta Drugs Ltd. | BETA | 2,474.26 | 62.88 | 9.95 | 18.65 | 22.17 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,421.1 | 34.54 | 6.99 | -2.6 | 16.92 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,416.82 | 171.93 | 3.18 | 13.9 | 12.97 |
| Hester Biosciences Ltd. | HESTERBIO | 2,111.45 | 15.25 | 4.57 | 16.17 | 14.12 |
Artemis Medicare Services Ltd. (ARTEMISMED) has a P/E ratio of 39.39x compared with the displayed peer median of 39.39x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 28.21% compares with a peer median of 16.17% across the companies shown in the table. ROCE stood at 26.35% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Artemis Medicare Services Ltd. (ARTEMISMED) has a market capitalisation of Rs 4,708.82 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Artemis Medicare Services Ltd.
- Reached a fresh 52-week high of Rs 308.05, indicating positive momentum.
- Strong ROE and ROCE compared to sector medians, reflecting profitability.
- Premium valuation with a P/B ratio of 7.98, above sector median.
- Largest market cap among peers, highlighting market leadership.
About Artemis Medicare Services Ltd.
Artemis Medicare Services Ltd. operates in the healthcare sector, providing a range of medical services. The company is known for its advanced healthcare facilities and comprehensive medical care offerings. With a focus on quality and innovation, Artemis has established itself as a leader in the industry, catering to a diverse patient base. Its strategic initiatives and robust infrastructure have contributed to its strong market position and growth trajectory.
Track Artemis Medicare Services Ltd. Share Price on Univest
Use Artemis Medicare Services Ltd. (ARTEMISMED) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Investors can track Artemis Medicare Services Ltd. Share Price, technical indicators, fundamental ratios, shareholding pattern, 52-week levels, and market insights on Univest. Stay updated with the latest market trends and data-driven analysis.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the current share price of Artemis Medicare Services Ltd.?
Ans. Artemis Medicare Services Ltd. Share Price is currently Rs 302.7, reflecting a 0.18% increase today. The stock reached a fresh 52-week high of Rs 308.05. The stock moved 0.18% during the session.
How does Artemis Medicare's P/E ratio compare to the sector?
Ans. Artemis Medicare's P/E ratio of 39.39 is above the sector median of 20.89, indicating a higher valuation compared to the sector. The company trades at a P/E ratio of 39.39x.
What is Artemis Medicare's market capitalisation?
Ans. Artemis Medicare Services Ltd. has a market capitalisation of Rs 4,708.82 crore, making it one of the larger companies in the healthcare sector. The company operates in the Healthcare sector.
How does Artemis Medicare's ROE compare to its peers?
Ans. Artemis Medicare's ROE of 28.21% is superior to most of its peers, indicating strong profitability and efficient use of equity. ROE stands at 28.21%. ROCE stands at 26.35%. The relevant peer median ROE is 10.92%.
What is the P/B ratio of Artemis Medicare?
Ans. Artemis Medicare Services Ltd. has a P/B ratio of 7.98, significantly higher than the sector median of 1.9, indicating a premium valuation. The company trades at a P/E ratio of 39.39x.
How does Artemis Medicare's market cap compare to the sector?
Ans. Artemis Medicare's market cap of Rs 4,708.82 crore is significantly above the sector median of Rs 139.24 crore, highlighting its substantial size. The company operates in the Healthcare sector. Its P/E ratio is 39.39x.
What is the ROCE of Artemis Medicare Services Ltd.?
Ans. Artemis Medicare Services Ltd. has a ROCE of 26.35%, well above the sector median of 13.29%, indicating efficient capital use. ROE stands at 28.21%. ROCE stands at 26.35%. The relevant peer median ROE is 10.92%.
